Dr Cyril Kamya, MD | |
317 S 14th St Ste 1, Herrin, IL 62948-3673 | |
(618) 988-6171 | |
Not Available |
Full Name | Dr Cyril Kamya |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 317 S 14th St Ste 1, Herrin, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245783588 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 036164014 (Illinois) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (New Mexico) | Secondary |
Entity Name | Southern Illinois Medical Services Nfp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770656837 PECOS PAC ID: 3678677390 Enrollment ID: O20070404000595 |
News Archive
As this year's threat from the West Nile virus continues, one infectious diseases expert at the University of Alabama at Birmingham says a vaccine is not in our near future, so people need to protect themselves.
A new inhalable dry powder treatment for lung cancer shows a significant increase in survival rates and is far less invasive than current treatment options, which frequently include radiation and surgery. This research is being presented at the 2010 International Pharmaceutical Federation Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition in New Orleans, La., Nov. 14-18.
Resveratrol is a naturally occurring polyphenolic phytochemical produced in several plants, especially grapes skin and seeds. One epidemiological study reported a positive association between moderate red wine consumption and a low incidence of cardiovascular disease, known as the "French Paradox."
Cenestra Health announced today that the U.S. Patent and Trademark Office has issued a key patent related to the company's high-purity omega-3 fatty acid formulations and their methods of use. U.S. Patent No. 7652068, entitled "Omega-3 Fatty Acid Formulations," covers a unique, high-purity formulation of the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Cyril Kamya, MD Po Box 3988, Carbondale, IL 62902-3988 Ph: (618) 457-5200 | Dr Cyril Kamya, MD 317 S 14th St Ste 1, Herrin, IL 62948-3673 Ph: (618) 988-6171 |
News Archive
As this year's threat from the West Nile virus continues, one infectious diseases expert at the University of Alabama at Birmingham says a vaccine is not in our near future, so people need to protect themselves.
A new inhalable dry powder treatment for lung cancer shows a significant increase in survival rates and is far less invasive than current treatment options, which frequently include radiation and surgery. This research is being presented at the 2010 International Pharmaceutical Federation Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition in New Orleans, La., Nov. 14-18.
Resveratrol is a naturally occurring polyphenolic phytochemical produced in several plants, especially grapes skin and seeds. One epidemiological study reported a positive association between moderate red wine consumption and a low incidence of cardiovascular disease, known as the "French Paradox."
Cenestra Health announced today that the U.S. Patent and Trademark Office has issued a key patent related to the company's high-purity omega-3 fatty acid formulations and their methods of use. U.S. Patent No. 7652068, entitled "Omega-3 Fatty Acid Formulations," covers a unique, high-purity formulation of the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun.
› Verified 8 days ago
William F. Hays, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3305 Logan Dr, Herrin, IL 62948 Phone: 618-997-4444 Fax: 618-993-1173 | |
Ellie Marie Bentley, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 220 S Park Ave Fl 3, Herrin, IL 62948 Phone: 618-942-2002 Fax: 618-351-6497 | |
Kristina Marie Potanos, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 220 S Park Ave Fl 3, Herrin, IL 62948 Phone: 618-942-2002 Fax: 618-351-6497 | |
Medha Suwanawongse, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 121 N 13th St, Herrin, IL 62948 Phone: 618-988-6025 Fax: 618-988-6024 | |
Dr. Robert Judson Brewer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 220 S Park Ave, 3rd Floor, Herrin, IL 62948 Phone: 618-942-2002 Fax: 618-351-6497 | |
Anne Hardy-henry, Surgery Medicare: Accepting Medicare Assignments Practice Location: 317 S 14th St Ste 1, Herrin, IL 62948 Phone: 618-988-6171 Fax: 618-351-6491 |